KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vertex Pharmaceuticals (VRTX) Shares Outstanding (Diluted Average): 2009-2024

Historic Shares Outstanding (Diluted Average) for Vertex Pharmaceuticals (VRTX) over the last 16 years, with Dec 2024 value amounting to $257.9 million.

  • Vertex Pharmaceuticals' Shares Outstanding (Diluted Average) fell 0.92% to $258.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $258.6 million, marking a year-over-year decrease of 0.92%. This contributed to the annual value of $257.9 million for FY2024, which is 1.00% down from last year.
  • Vertex Pharmaceuticals' Shares Outstanding (Diluted Average) amounted to $257.9 million in FY2024, which was down 1.00% from $260.5 million recorded in FY2023.
  • In the past 5 years, Vertex Pharmaceuticals' Shares Outstanding (Diluted Average) registered a high of $263.4 million during FY2020, and its lowest value of $257.9 million during FY2024.
  • Its 3-year average for Shares Outstanding (Diluted Average) is $259.2 million, with a median of $259.1 million in 2022.
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first rose by 1.04% in 2020, then decreased by 1.33% in 2021.
  • Over the past 5 years, Vertex Pharmaceuticals' Shares Outstanding (Diluted Average) (Yearly) stood at $263.4 million in 2020, then fell by 1.33% to $259.9 million in 2021, then declined by 0.31% to $259.1 million in 2022, then rose by 0.54% to $260.5 million in 2023, then decreased by 1.00% to $257.9 million in 2024.